63 results
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on the Israeli population … milestones based on defined sales targets of motixafortide in the Territory. Additionally, we are eligible to receive tiered, double-digit royalties
F-3
BLRX
Bioline Rx Ltd
29 Dec 23
Shelf registration (foreign)
4:15pm
, hostile infiltrations and terrorism against civilian targets in various parts of Israel, which have negatively affected business conditions in Israel … and military targets. Hamas also launched extensive rocket attacks on Israeli population and industrial centers located along Israel’s border with the Gaza Strip
6-K
EX-99
BLRX
Bioline Rx Ltd
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also … based on defined sales targets of motixafortide in the Territory. In addition, the Company is eligible to receive tiered double-digit royalties
6-K
EX-99
vcosn5np3
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
6-K
EX-99
4tnqiutxzcpd52r1
12 Oct 23
BioLineRx Announces Closing of Exclusive License Agreement to Motixafortide
7:14am
6-K
EX-99
fimu6iclbse1fwvxrmxe
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
EX-99
p6z7ckn1y0lsqntun4fn
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
tm76tv9jp
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
81aos7mf52fo5t4aq
15 Sep 22
Current report (foreign)
8:39am
6-K
EX-99
5xaw8jc
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-10.1
ydro7wbjk
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-99
z1ebhc4 ytjs6
16 Dec 20
Current report (foreign)
8:00am
6-K
EX-10.1
xktleafad5mzx
25 Sep 20
Current report (foreign)
4:33pm
6-K
EX-99
rtmrvi5 axwkh
25 Sep 19
BioLineRx Announces Dosing of First Patient in Part 2 of
7:00am